These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12744901)

  • 81. Seroprevalence of measles antibodies among high-risk healthcare workers in Auckland, New Zealand: additional justification for assumption of age-determined immunity based on local data.
    Williamson D; Freeman J; Austin P; Allum C; Roberts S
    Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1082-4. PubMed ID: 20804375
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Epidemic measles in young adults. Clinical, epidemiologic, and serologic studies.
    Krause PJ; Cherry JD; Deseda-Tous J; Champion JG; Strassburg M; Sullivan C; Spencer MJ; Bryson YJ; Welliver RC; Boyer KM
    Ann Intern Med; 1979 Jun; 90(6):873-6. PubMed ID: 443682
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Immune status of health care workers to measles virus: evaluation of protective titers in four measles IgG EIAs.
    Dorigo-Zetsma JW; Leverstein-van Hall MA; Vreeswijk J; de Vries JJ; Vossen AC; Ten Hulscher HI; Kerkhof J; Smits GP; Ruijs WL; Koopmans MP; Binnendijk RS
    J Clin Virol; 2015 Aug; 69():214-8. PubMed ID: 26209410
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Haemagglutination inhibition antibody levels one year after natural measles infection and vaccination.
    Eghafona NO; Ahmad AA; Ezeokoli CD; Emejuaiwe SO
    Microbios; 1991; 67(274):33-6. PubMed ID: 1758308
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Two cases of mild IgM-negative measles in previously vaccinated adults, the Netherlands, April and July 2011.
    van den Hoek A; Sonder GJ; Scholing M; Gijselaar D; van Binnendijk RS
    Euro Surveill; 2011 Dec; 16(48):. PubMed ID: 22172302
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Age-dependence of measles immunization failures].
    Giesecke H; Brendel P; Schmidt J; Schlenk B
    Z Gesamte Hyg; 1980; 26(10):764-67. PubMed ID: 7467503
    [No Abstract]   [Full Text] [Related]  

  • 87. [Study of measles history, vaccination, antibody status, and vaccination effectiveress for school teachers].
    Ichinohe S; Ogawa T
    Kansenshogaku Zasshi; 2011 May; 85(3):263-7. PubMed ID: 21706846
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Herd immunity and measles.
    Fox JP
    Rev Infect Dis; 1983; 5(3):463-6. PubMed ID: 6879000
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [The use of computers and mathematical methods for optimizing epidemic control measures with respect to measles infection].
    Bezuglova MS; Rusakova EV; Frank KD; Drynov ID; Vasil'eva VI; Filatov NN; Mironova VF
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Sep; (9):44-7. PubMed ID: 1759519
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Measles control--can measles virus inhibitors make a difference?
    Plemper RK; Snyder JP
    Curr Opin Investig Drugs; 2009 Aug; 10(8):811-20. PubMed ID: 19649926
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Deciphering the relative weights of demographic transition and vaccination in the decrease of measles incidence in Italy.
    Merler S; Ajelli M
    Proc Biol Sci; 2014 Feb; 281(1777):20132676. PubMed ID: 24403333
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The epidemiology of measles: thirty years of vaccination.
    Clements CJ; Cutts FT
    Curr Top Microbiol Immunol; 1995; 191():13-33. PubMed ID: 7789156
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Backward bifurcations and multiple equilibria in epidemic models with structured immunity.
    Reluga TC; Medlock J; Perelson AS
    J Theor Biol; 2008 May; 252(1):155-65. PubMed ID: 18325538
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Measles: extinction or evolution?
    McCombie SC
    Med Hypotheses; 1984 Mar; 13(3):351-3. PubMed ID: 6717325
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Epidemiology of communicable disease in small populations.
    Rhodes CJ; Butler AR; Anderson RM
    J Mol Med (Berl); 1998 Feb; 76(2):111-6. PubMed ID: 9500676
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Estimation of individual and population vaccination effectiveness from time-to-event data.
    Haber M; Ndikuyeze A
    Stat Med; 1998 Nov; 17(22):2617-23. PubMed ID: 9839352
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Estimating the measles effective reproduction number in Australia from routine notification data.
    Chiew M; Gidding HF; Dey A; Wood J; Martin N; Davis S; McIntyre P
    Bull World Health Organ; 2014 Mar; 92(3):171-7. PubMed ID: 24700976
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Measles immunity in emergency medical providers.
    Gongola A; Reif R; Jensen H; Hutchison M; Mason C; Sexton KW
    Vaccine; 2020 Sep; 38(41):6350-6351. PubMed ID: 32798143
    [No Abstract]   [Full Text] [Related]  

  • 99. Measles in non-human primates.
    Dogadov DI; Kyuregyan KK; Goncharenko AM; Mikhailov MI
    J Med Primatol; 2023 Apr; 52(2):135-143. PubMed ID: 36440505
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Implications of vaccination and waning immunity.
    Heffernan JM; Keeling MJ
    Proc Biol Sci; 2009 Jun; 276(1664):2071-80. PubMed ID: 19324753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.